Inpatient Orders for Acute Urinary Tract Infection
For hospitalized patients with acute complicated UTI, initiate empirical intravenous antibiotic therapy with a fluoroquinolone, aminoglycoside with or without ampicillin, or a third-generation cephalosporin, obtain urine culture before the first antibiotic dose, and plan for a 5-7 day total duration if using a fluoroquinolone or 7 days for non-fluoroquinolones once the patient is clinically improving 1, 2.
Initial Assessment and Diagnostic Orders
Order the following immediately upon admission:
- Urine culture with antimicrobial susceptibility testing - mandatory before starting antibiotics to guide definitive therapy 1, 3
- Urinalysis with reflex to culture
- Complete blood count
- Basic metabolic panel (assess renal function for antibiotic dosing)
- Blood cultures only if: uncertain diagnosis, immunocompromised, or suspected hematogenous infection 3, 4
Avoid routine imaging, serum inflammatory markers, or blood cultures in uncomplicated cases 3.
Empirical Antibiotic Selection
First-Line IV Options for Hospitalized Patients:
Choose based on local resistance patterns and patient risk factors:
- Fluoroquinolones (ciprofloxacin 400mg IV q12h or levofloxacin 750mg IV daily) - preferred if local resistance <10% 4
- Third-generation cephalosporins (ceftriaxone 1-2g IV daily) - avoid if ESBL risk 4
- Aminoglycoside (gentamicin or tobramycin) with or without ampicillin - particularly for sepsis or multidrug-resistant organism risk 3, 4
Special Considerations:
- Sepsis or ESBL risk: Use carbapenems or agents with activity against extended-spectrum beta-lactamase-producing organisms 3
- Men with febrile UTI: Consider acute bacterial prostatitis - plan for 10-14 days total duration 2
- Pregnant patients: Admit all cases, use parenteral therapy initially due to elevated complication risk 3
Transition to Oral Therapy
Switch from IV to oral antibiotics when:
- Patient is clinically improving (typically 48-72 hours)
- Afebrile for 24 hours
- Tolerating oral intake
- Susceptibility results available 2
Oral step-down options (based on susceptibilities):
- Fluoroquinolones: ciprofloxacin 500-750mg PO q12h or levofloxacin 500-750mg PO daily 1
- Cefpodoxime 200-400mg PO q12h 1
- TMP-SMX (if susceptible and local resistance <20%)
- Amoxicillin-clavulanate 875-125mg PO q8-12h 1
Duration of Therapy
Total antibiotic duration from first effective dose 2:
- 5-7 days for fluoroquinolones (conditional recommendation, moderate certainty) 2
- 7 days for non-fluoroquinolones (conditional recommendation, very low certainty) 2
- 10-14 days for suspected acute bacterial prostatitis in men 2
This shorter duration recommendation applies even with concurrent Gram-negative bacteremia if the patient is clinically improving 2.
Supportive Care Orders
- IV fluids if dehydrated or unable to tolerate oral intake
- Antipyretics for fever management
- Antiemetics if nausea/vomiting present
- Pain management (avoid NSAIDs if renal impairment)
Monitoring Parameters
- Daily assessment of clinical response (fever curve, flank pain, urinary symptoms)
- Expect improvement within 48-72 hours 3, 4
- Repeat cultures if no clinical improvement by 72 hours 4
- Renal function monitoring if using aminoglycosides (nephrotoxicity risk) or plazomicin 1
Red Flags Requiring Imaging or Urologic Consultation
Order CT abdomen/pelvis with contrast if:
- No clinical improvement after 48-72 hours of appropriate antibiotics 3, 4
- Suspected urinary obstruction
- Suspected renal or perinephric abscess
- Recurrent infections suggesting anatomic abnormality
Urgent urology referral for concurrent urinary tract obstruction requiring decompression 3.
Common Pitfalls to Avoid
- Do not use ceftriaxone empirically if patient has risk factors for ESBL organisms (recent antibiotics, healthcare exposure, recurrent UTIs) 5
- Do not continue antibiotics beyond 7 days in uncomplicated cases - this promotes resistance without added benefit 2
- Do not use oral beta-lactams as empiric therapy without higher dosing - they may require dose adjustments for efficacy 2
- Do not discharge patients who cannot tolerate oral therapy or have persistent vomiting 4
Discharge Planning
- Repeat urine culture 1-2 weeks after antibiotic completion 4
- Counsel on hydration and complete antibiotic course
- Return precautions: persistent fever, worsening pain, inability to tolerate oral intake